Alerts will be sent to your verified email
Verify Email
SMSPHARMA
|
SMS Pharmaceuticals
|
Hester Biosciences
|
Morepen Laboratories
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
R&D as a % of Total Sales
|
1.61 % | 1.91 % | 0.87 % |
|
Financials
|
|||
|
5 yr Average ROE
|
9.06 % | 10.99 % | 13.43 % |
|
5yr average Equity Multiplier
|
1.9 | 2.14 | 1.68 |
|
5yr Average Asset Turnover Ratio
|
0.64 | 0.46 | 1.29 |
|
5yr Avg Net Profit Margin
|
7.28 % | 11.57 % | 5.93 % |
|
Price to Book
|
3.25 | 5.15 | 2.2 |
|
P/E
|
28.43 | 43.0 | 27.46 |
|
5yr Avg Cash Conversion Cycle
|
93.25 Days | 60.38 Days | 12.78 Days |
|
Inventory Days
|
116.73 Days | 100.79 Days | 54.64 Days |
|
Days Receivable
|
93.46 Days | 89.02 Days | 65.45 Days |
|
Days Payable
|
85.64 Days | 127.62 Days | 96.29 Days |
|
5yr Average Interest Coverage Ratio
|
4.77 | 6.96 | 39.11 |
|
5yr Avg ROCE
|
12.12 % | 11.14 % | 15.77 % |
|
5yr Avg Operating Profit Margin
|
17.98 % | 22.71 % | 8.68 % |
|
5 yr average Debt to Equity
|
0.53 | 0.75 | 0.04 |
|
5yr CAGR Net Profit
|
9.56 % | -4.4 % | 3.98 % |
|
5yr Average Return on Assets
|
4.75 % | 5.28 % | 7.67 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
66.26 % | 53.73 % | 35.65 % |
|
Share Pledged by Promoters
|
32.49 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
2.09 % | 0.0 | -1.09 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
3.03 % | -0.03 % | 0.0 |
|
SMS Pharmaceuticals
|
Hester Biosciences
|
Morepen Laboratories
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
-
|
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
-
|